Overview
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 9, 2024 | Dutch startup Whispp uses AI to give people with speech impediments a strong new voice; raises €750K | Read this article in: Leiden-based Whispp, a Dutch AI startup, has raised €750K in a seed round of funding led by Eindhoven’s LUMO Labs, with additional funds from Leiden University holding Libertatis Ergo Holding BV (LEH) and other angel i... |
| Jul 19, 2023 | Dutch biotech River BioMedics raises €2M to discover, develop novel cardiac drugs | Read this article in: Enschede-based River BioMedics, a Dutch biotech company focused on cardiac drug discovery using 3D human cardiac models, announced that it has secured €2M in a seed round of funding. The Dutch startup aims to progress ... |
| Apr 17, 2023 | Dutch startup OncoLize secures €1.5M for treating rare, deadly tumours ‘from the inside’ | Netherlands-based OncoLize, a company that develops injectable drug depots to treat rare and deadly tumour diseases, announced on Thursday, April 13, that it has secured $1.7M (approximately €1.54M) in funding. With this financing, the comp... |
Reviews 0
FAQ about Libertatis Ergo Holding B.V.
What has the press written about Libertatis Ergo Holding B.V.?
Parsers VC has collected 4 articles mentioning Libertatis Ergo Holding B.V., among them “Dutch startup Whispp uses AI to give people with speech impediments a strong new voice; raises €750K” (Jan 9, 2024) and “Dutch biotech River BioMedics raises €2M to discover, develop novel cardiac drugs” (Jul 19, 2023).
Is Libertatis Ergo Holding B.V. still active?
Yes, Libertatis Ergo Holding B.V. is active; its latest activity on Parsers VC dates from Jan 13, 2025.